This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

7 Stocks Under $10 Making Big Moves


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Repligen (RGEN) engages in the manufacture and supply of biologic products used to manufacture biologic drugs. This stock is trading up 9.9% to $4.31 in recent trading.

Today's Range: $4.02-$4.36

52-Week Range: $2.90-$7.29

Volume: 176,000

Three-Month Average Volume: 192,703

Shares of RGEN are ripping higher today after the company raised its fiscal 2012 revenue guidance from $52 million to $55 million to its current estimate of $55 million to $57 million. The company also raised its net profit estimate from $5 million to $7 million for fiscal 2012.

>>5 Biotech Stocks Poised for Breakouts

From a technical perspective, RGEN is moving up sharply here back above both its 50-day at $4.17 and its 200-day at $4.21 with decent volume. This move is quickly pushing RGEN within range of triggering a near-term breakout trade. That trade will hit once RGEN takes out some near-term overhead resistance at $4.32 to $4.57 with high volume.

Traders should now look for long-biased trades as long as RGEN is trending above its 50-day and 200-day moving averages, and then once it sustains a move or close above $4.32 to $4.57 with volume that's near or above 192,703 shares. If we get that action soon, then RGEN has a great chance of filling some of a previous gap-down from April that took the stock from $7.30 to $4. The probability of filling that gap will increase once RGEN takes out $5 to $5.14 with heavy volume.
2 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
EXM $0.00 0.00%
AMSC $9.64 0.31%
GSS $0.70 2.60%
PQ $0.84 1.70%
SMA $9.27 -0.43%


Chart of I:DJI
DOW 17,679.10 -151.66 -0.85%
S&P 500 2,055.48 -20.33 -0.98%
NASDAQ 4,749.5590 -55.7320 -1.16%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs